Home
Company directory
Life science ecosystem
A whole range of premises
Living and working
Team
Media

Accueil » Media

Media

Press releases

Download the press releases on SMO Biopôle Clermont-Limagne and its members.

types de communiqués

SMO Biopôle Clermont-Limagne

Companies

Alphanosos
Aptys Pharma
Carbios
Carbogen Amcis
GIMRA
Icare
Jacquet
Limagrain
METabolic EXplorer
Oncosema
Sabi Agri
Valbiotis
Végépolys Valley

13/03/2023 - Valbiotis

Valbiotis announces the last visit of the last patient in the Phase II/III REVERSE-IT study on TOTUM•63, in partnership with Nestlé Health Science.

09/02/2023 - METabolic EXplorer

2022 turnover: €226.6 million (IN FRENCH).

07/02/2023 - METabolic EXplorer

Approval of the agreement concluded by METabolic EXplorer with its main partners on 23 December 2022 under the conciliation procedure (IN FRENCH).

03/02/2023 - Carbogen Amcis

Inauguration of the new production unit of CARBOGEN AMCIS SAS at Biopôle Clermont-Limagne (Saint-Beauzire, Puy de Dôme) Friday, February 3, 2023 (IN FRENCH).

30/01/2023 - Valbiotis

Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure.

27/01/2023 - METabolic EXplorer

Provisional suspension of the liquidity contract (IN FRENCH).

13/01/2023 - METabolic EXplorer

2023 Financial Schedule (IN FRENCH).

12/01/2023 - METabolic EXplorer

Provision of preparatory documents for the Extraordinary General Assembly (IN FRENCH).

10/01/2023 - Valbiotis

Valbiotis announces its roadmap for 2023: a pivotal year in the execution of its clinical, industrial and commercial strategy.

27/12/2022 - METabolic EXplorer

METabolic EXplorer secures financing for deployment of its strategy.

15/12/2022 - Valbiotis

Valbiotis announces the signature of a research partnership in intestinal microbiota with the MEDIS Unit from the Clermont Auvergne University.

09/11/2022 - Icare

e Icare Group commits to the 2022 Octobre Rose operation

08/11/2022 - METabolic EXplorer

Consolidated sales for the third quarter of 2022: €54.8 million (IN FRENCH).

27/10/2022 - Valbiotis

Valbiotis will present significant preclinical results for its active substance TOTUM•448 against fatty liver diseases (NAFL and NASH), at the annual meeting of the American Association for the Study of Liver Diseases (AASLD).

07/10/2022 - Valbiotis

Valbiotis accelerates its marketing strategy.

06/10/2022 - Limagrain

INVERS and the cooperatives Limagrain, Oxyane and Eurea create INVERS AURA, the first agricultural insect production line (IN FRENCH).

06/10/2022 - Limagrain

Signing of a partnership agreement between Limagrain and VetAgro Sup on 5 October at the Livestock Summit (IN FRENCH).

04/10/2022 - Aptys Pharma

Aptys Pharma participates to Meet-up Pharma, on October 8 in Clermont-Ferrand (IN FRENCH).

03/10/2022 - Valbiotis

Valbiotis presents additional positive results from the HEART clinical study on TOTUM•070 for hypercholesterolemia

03/10/2022 - METabolic EXplorer

2022 Semi-Annual Results and Release of Semi-Annual Financial Report (IN FRENCH).

« Previous 1 2 3 4 … 6 Next »

SMO Biopôle Clermont-Limagne
Unrestricted-Public-Sector Association
How
to find us
Manage
my cookies
Legal notice

Colonne de pied de page #1

We use cookies to guarantee the best experience on our site, to make statistics, to offer you third party services such as video like Youtube, social networks sharing. By clicking on validate and closing this banner, you accept the deposit of cookies.Accept Refuse More information

You can revoke your consent at any time by using the "Revoke Consent" button.Revoke consent